Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Selected Disorders of the Cardiovascular System

  • Chapter
Taylor’s Cardiovascular Diseases

  • 605 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lorell BH. Pericardial diseases. In: Braunwald E, ed. Heart disease: a textbook of cardiovascular medicine, 5th ed. Philadelphia: WB Saunders, 1997;1478–505.

    Google Scholar 

  2. Myers RBH, Spodick DH. Constrictive pericarditis: clinical and pathophysiologic characteristics. Am Heart J 1999;138(2):219–32.

    Article  PubMed  CAS  Google Scholar 

  3. Chan TC, Brady WJ, Pollack M. Electrocardiographic manifestations: acute myopericarditis. J Emerg Med 1999;17(5):865–72.

    Article  PubMed  CAS  Google Scholar 

  4. Vaitkus PT, LeWinter MM. Pericardial disease. In: Bone RC, Alpert JS, eds. Current practice of medicine. Philadelphia: Churchill Livingstone, 1996;II:21.1–8.

    Google Scholar 

  5. Osterberg L, Vagelos R, Atwood JE. Case presentation and review: constrictive pericarditis. West J Med 1998;169(4):232–9.

    PubMed  CAS  Google Scholar 

  6. Sagrista-Sauleda J, Barrabes JA, Permanyer-Miralda G, Soler-Soler J. Purulent pericarditis: review of a 20-year experience in a general hospital. J Am Coll Cardiol 1993;22:1661–5.

    PubMed  CAS  Google Scholar 

  7. Caforio ALP, McKenna WJ. Recognition and optimum management of myocarditis. Drugs 1996;52(4):515–25.

    PubMed  CAS  Google Scholar 

  8. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death. Circulation 1999;99(8):1091–100.

    PubMed  CAS  Google Scholar 

  9. Pisani B, Taylor DO, Mason JW. Inflammatory myocardial diseases and cardiomyopathies. Am J Med 1997;102(5):459–69.

    Article  PubMed  CAS  Google Scholar 

  10. Mendes LA, Picard MH, Dec GW, Hartz VL, Palacios IF, Davidoff R. Ventricular remodeling in active myocarditis. Am Heart J 1999;138(2):303–8.

    Article  PubMed  CAS  Google Scholar 

  11. Parrillo JE. Myocarditis: How should we treat in 1998? J Heart Lung Transplant 1998;17(10):941–4.

    PubMed  CAS  Google Scholar 

  12. Rezkalla SH, Raikar S, Kloner RA. Treatment of viral myo-carditis with focus on captopril. Am J Cardiol 1996;77(8):634–7.

    Article  PubMed  CAS  Google Scholar 

  13. Durack DT. Infective endocarditis. In: Alexander RW, Schlant RC, Fuster V, eds. Hurst’s the heart, arteries and veins, 9th edition. New York: McGraw-Hill, 1997;2205–39.

    Google Scholar 

  14. Cunha BA, Gill MV, Lazar JM. Acute infective endocarditis: diagnostic and therapeutic approach. Infect Dis Clin North Am 1996;10(4):811–34.

    Article  PubMed  CAS  Google Scholar 

  15. Brook MM. Pediatric bacterial endocarditis: treatment and prophylaxis. Pediatr Clin North Am 1999;46(2):275–87.

    Article  PubMed  CAS  Google Scholar 

  16. Kemp WE, Citrin B, Byrd BF. Echocardiography in infective endocarditis. South Med J 1999;92(8):744–54.

    PubMed  Google Scholar 

  17. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994;96(3):200–9.

    PubMed  CAS  Google Scholar 

  18. Cecchi E, Parrini I, Chinaglia A, et al. New diagnostic criteria for infective endocarditis: a study of sensitivity and specificity. Eur Heart J 1997;18(7):1149–56.

    PubMed  CAS  Google Scholar 

  19. Hoen B, Beguinot I, Rabaud C, et al. The Duke criteria for diagnosing infective endocarditis are specific: analysis of 100 patients with acute fever or fever of unknown origin. Clin Infect Dis 1996;23(2):298–302.

    PubMed  CAS  Google Scholar 

  20. Dodds GA, Sexton DJ, Durack DT, Bashore TM, Corey GR, Kisslo J. Negative predictive value of the Duke criteria for infective endocarditis. Am J Cardiol 1996;77(5):403–7.

    Article  PubMed  CAS  Google Scholar 

  21. Stockheim JA, Chadwick EG, Kessler S, et al. Are the Duke criteria superior to the Beth Israel criteria for the diagnosis of infective endocarditis in children? Clin Infect Dis 1998;27(6):1451–6.

    PubMed  CAS  Google Scholar 

  22. Del Pont JM, De Cicco LT, Vartalitis C, et al. Infective endocarditis in children: clinical analyses and evaluation of two diagnostic criteria. Pediatr Infect Dis J 1995;14(12):1079–86.

    PubMed  Google Scholar 

  23. Nettles RE, McCarty DE, Corey GR, Li J, Sexton DJ. An evaluation of the Duke criteria in 25 pathologically confirmed cases of prosthetic valve endocarditis. Clin Infect Dis 1997;25(6):1401–3.

    PubMed  CAS  Google Scholar 

  24. Giessel BE, Koenig CJ, Blake RL. Management of bacterial endocarditis. Am Fam Physician 2000;61(6):1725–32.

    PubMed  CAS  Google Scholar 

  25. Wilson WR, Karchmer AW, Dajani AS, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. JAMA 1995;274(21): 1706–13.

    Article  PubMed  CAS  Google Scholar 

  26. Moon MR, Stinson EB, Miller DC. Surgical treatment of endocarditis. Prog Cardiovasc Dis 1997;40(3):239–64.

    PubMed  CAS  Google Scholar 

  27. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996;93(5):841–2.

    PubMed  CAS  Google Scholar 

  28. Elliott P. Diagnosis and management of dilated cardiomyopathy. Heart 2000;84(1):106–12.

    Article  PubMed  CAS  Google Scholar 

  29. McKelvie RS, Yusuf S, Pericak D, et al. Comparison of candesartan, enalapril and their combination in congestive cardiac failure. Randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. Circulation 1999;100(10):1056–64.

    PubMed  CAS  Google Scholar 

  30. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341(10):709–17.

    Article  PubMed  CAS  Google Scholar 

  31. Louie EK, Edwards LC III. Hypertrophic cardiomyopathy. Prog Cardiovasc Dis 1994;36(4):275–308.

    PubMed  CAS  Google Scholar 

  32. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 1995;92(7): 1680–92.

    PubMed  CAS  Google Scholar 

  33. Maron BJ. Hypertrophic cardiomyopathy. In: Alexander RW, Schlant RC, Fuster V, eds. Hurst’s the heart, arteries and veins, 9th edition. New York: McGraw-Hill, 1997;2057–74.

    Google Scholar 

  34. Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med 1997;336(4):267–76.

    Article  PubMed  CAS  Google Scholar 

  35. Barst RJ. Recent advances in the treatment of pediatric pulmonary artery hypertension. Pediatr Clin North Am 1999;46(2):331–45.

    Article  PubMed  CAS  Google Scholar 

  36. Peacock AJ. Primary pulmonary hypertension. Thorax 1999;54:1107–18.

    PubMed  CAS  Google Scholar 

  37. Krowka MJ. Pulmonary hypertension: diagnostics and therapeutics. Mayo Clinic Proc 2000;75:625–30.

    CAS  Google Scholar 

  38. Fowkes FGR. Epidemiology of peripheral vascular disease. Atherosclerosis 1997;131(suppl):29–31.

    Google Scholar 

  39. Powers KB, Vacek JL, Lee S. Noninvasive approaches to peripheral vascular disease: what’s new in evaluation and treatment? Postgrad Med 1999;106(3):52–64.

    PubMed  CAS  Google Scholar 

  40. Jackson MR, Clagett GP. Antithrombotic therapy in peripheral arterial occlusive disease. Chest 1998;114(5 suppl):666S–82S.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. David E. Anisman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Family Medicine, Oregon Health & Science University School of Medicine, Portland, OR, 97201-3098, USA

    Robert B. Taylor M.D. (Professor Emeritus) & Scott A. Fields M.D. (Professor and Vice Chairman) (Professor Emeritus) &  (Professor and Vice Chairman)

  2. Department of Family and Community Medicine, Medical College of Wisconsin, Milwaukee, WI, 53226-0509, USA

    Alan K. David M.D. (Professor and Chairman) (Professor and Chairman)

  3. Department of Family Medicine, University of Mississippi School of Medicine, Jackson, MS, 39216-4500, USA

    D. Melessa Phillips M.D. (Professor and Chairman) (Professor and Chairman)

  4. Department of Family and Preventive Medicine, University of California, San Diego School of Medicine, San Diego, CA, 92103-0801

    Joseph E. Scherger M.D., M.P.H. (Clinical Professor) (Clinical Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Anisman, D.E. (2005). Selected Disorders of the Cardiovascular System. In: Taylor, R.B., David, A.K., Phillips, D.M., Fields, S.A., Scherger, J.E. (eds) Taylor’s Cardiovascular Diseases. Springer, New York, NY. https://doi.org/10.1007/0-387-27276-3_11

Download citation

  • DOI: https://doi.org/10.1007/0-387-27276-3_11

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-22351-3

  • Online ISBN: 978-0-387-27276-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation